Annals ofOncology

Volume: 2 - Number: 12 - October 15, 2002

Noticias del día

Case

Elevated -foetoprotein and hepatic metastases it\'s not always what it seems

A paraneoplastic syndrome mimicking extrauterine pregnancy

Massive cavitation of solid pulmonary metastatic lesions in a breast cancer patient: a case report

Seguimos creciendo para Brindar el mejor servicio

Fase I Study

Phase I study of twelve-day prolonged infusion of high-dose ifosfamide and doxorubicin as first-line chemotherapy in adult patients with advanced soft tissue sarcomas

Head and Neck Carcinomas

Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type

Hematology and Oncology

Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens

Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin’s Lymphoma Classification Project

Seguimos creciendo para Brindar el mejor servicio

Lung Cancer

Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study

Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II study

Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy aunque mas costoo efectivo: a study randomized in II fase of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated

Seguimos creciendo para Brindar el mejor servicio

Sarcoma

FDG PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging

Urogenital Tumours

A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinoma

Extragonadal retroperitoneal germ cell tumor: evidence of origin in the testis

A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial

Diabetes e Incretinas

Buscador

Copyright © Dr. Mario I. Cámera .:. Powered by ForamenAlojado en ...